Marco A Calzado
@marcoacalzado.bsky.social
130 followers
210 following
13 posts
Professor @uco.es, Scientist @IMIBIC, Immunologist, Molecular Biologist, Father, and Technology Enthusiast.
Posts
Media
Videos
Starter Packs
Reposted by Marco A Calzado
Paolo Crosetto
@paolocrosetto.bsky.social
· Jun 15
Springer Nature Discovers MDPI – The Strain on Scientific Publishing
Home page for the paper ‘The Strain on Scientific Publishing’ by Mark A Hanson, Dan Brockington, Paolo Crosetto and Pablo Gomez Barreiro
the-strain-on-scientific-publishing.github.io
Reposted by Marco A Calzado
Seth Cheetham
@sethcheetham.bsky.social
· Jun 10
The design, manufacture and LNP formulation of mRNA for research use
Nature Protocols - This protocol describes simple, small-scale laboratory production of mRNA for research and preclinical use. This includes sequence design, DNA template production, mRNA synthesis...
rdcu.be
Reposted by Marco A Calzado
Science Magazine
@science.org
· May 23
Silencing mitochondrial gene expression in living cells
Mitochondria fulfill central functions in metabolism and energy supply. They express their own genome, which encodes key subunits of the oxidative phosphorylation system. However, central mechanisms u...
scim.ag
Reposted by Marco A Calzado
Reposted by Marco A Calzado
Molecular Cell
@cp-molcell.bsky.social
· May 19
Proteasome: An antibiotic arsenal in anti-bacterial innate immunity
The function of the proteasome besides degrading protein remains enigmatic. Goldberg et al. demonstrate that proteasomes can process proteins into antimicrobial peptides (AMPs) to ward off bacterial infection, revealing a new function of proteasomes in innate immunity.
dlvr.it
Reposted by Marco A Calzado
Reposted by Marco A Calzado
Cancer Cell
@cp-cancercell.bsky.social
· May 12
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
Xu et al. conduct a single-arm, phase 2 study evaluating the efficacy and safety of nivolumab plus induction chemotherapy and radiotherapy in patients with nasopharyngeal carcinoma. This combination therapy sparing concurrent cisplatin improves failure-free survival compared with a historical benchmark, and has low toxicity and favorable patient-reported tolerability and quality-of-life.
dlvr.it
Reposted by Marco A Calzado
Nature
@nature.com
· May 5
Cell cycle duration determines oncogenic transformation capacity - Nature
Total cell cycle duration is a key hallmark of cancer initiation, and determines whether defects in apoptosis, senescence, immune surveillance, angiogenesis, DNA repair, polarity and proliferation lead to cancer development.
go.nature.com
Reposted by Marco A Calzado